ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,890.10
-0.91%
S&P ASX All Technology
3,489.20
-4.01%
Brent Oil
69.935
1.30%
US Dollar vs AUD
1.59144
-0.08%
Bitcoin
81,108.18
3.35%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Csl Ltd (QX) (CSLLY) Share Price

Csl Ltd (QX)

Csl Ltd (QX) (CSLLY)

USOTC
78.07
-0.65
( -0.83% )
Updated: 02:20:32
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
78.07
Bid
78.01
Offer
78.25
Volume
26,170
78.00 Day's Range 79.063
77.37 52 Week Range 109.00
Market Cap
75.455B
Previous Close
78.72
Open
78.00
Last Trade
318
@
78.07
Last Trade Time
02:20:32
Financial Volume
US$ 2,047,498
VWAP
78.2384
Average Volume (3m)
85,482
Shares Outstanding
966,505,458
Dividend Yield
-
PE Ratio
92.04
Earnings Per Share (EPS)
2.73
Revenue
14.69B
Net Profit
2.64B

About Csl Ltd (QX)

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.csl.com.au
Headquarters
Melbourne, Victoria, Aus
Founded
1916
Csl Ltd (QX) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker CSLLY. The last closing price for Csl (QX) was US$78.72. Over the last year, Csl (QX) shares have traded in a share price range of US$ 77.37 to US$ 109.00.

Csl (QX) currently has 966,505,458 shares in issue. The market capitalisation of Csl (QX) is US$76.08 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 92.04.

Ask ADVFN Intelligence (AI)

CSLLY Latest News

More News

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
26 July 2023
CSLLY (-0.83%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.88-4.734594264881.9584.25785833381.74180903DR
4-2.15-2.6801296434880.2285.33777.379348881.8461082DR
12-12.33-13.63938053190.490.477.378548284.86216418DR
26-22.455-22.3377269336100.525105.6677.376552487.84408182DR
52-11.53-12.868303571489.610977.374695090.09674414DR
156-16.35-17.316246557994.42110.2571.516484090.95672066DR
260-21.195-21.35193673599.265117.9871.515934594.87595826DR

CSLLY - Frequently Asked Questions (FAQ)

What is the current Csl (QX) share price?
The current share price of Csl (QX) is US$ 78.07
How many Csl (QX) shares are in issue?
Csl (QX) has 966,505,458 shares in issue
What is the market cap of Csl (QX)?
The market capitalisation of Csl (QX) is USD 76.08B
What is the 1 year trading range for Csl (QX) share price?
Csl (QX) has traded in the range of US$ 77.37 to US$ 109.00 during the past year
What is the PE ratio of Csl (QX)?
The price to earnings ratio of Csl (QX) is 92.04
What is the cash to sales ratio of Csl (QX)?
The cash to sales ratio of Csl (QX) is 16.55
What is the reporting currency for Csl (QX)?
Csl (QX) reports financial results in USD
What is the latest annual turnover for Csl (QX)?
The latest annual turnover of Csl (QX) is USD 14.69B
What is the latest annual profit for Csl (QX)?
The latest annual profit of Csl (QX) is USD 2.64B
What is the registered address of Csl (QX)?
The registered address for Csl (QX) is 655 ELIZABETH STREET, MELBOURNE, VICTORIA, 3000
What is the Csl (QX) website address?
The website address for Csl (QX) is www.csl.com.au
Which industry sector does Csl (QX) operate in?
Csl (QX) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
400
INTKIndustrial Nanotech Inc (PK)
US$ 0.0001
(9,900.00%)
20k
GBXIGBX International Group Inc (CE)
US$ 0.0001
(9,900.00%)
4k
CBGLCannabis Global Inc (PK)
US$ 0.0001
(9,900.00%)
4.5M
ANTHAnthera Pharmaceuticals Inc (CE)
US$ 0.0001
(9,900.00%)
8.72k
FBECFBEC Worldwide Inc (CE)
US$ 0.000001
(-99.80%)
10k
VAXXVaxxinity Inc (CE)
US$ 0.0001
(-99.80%)
1.12k
PLPLPlandai Biotechnology Inc (PK)
US$ 0.000001
(-99.00%)
200k
MDCNMedican Enterprises Inc (PK)
US$ 0.000001
(-99.00%)
39k
GNCAQGenocea Biosciences Inc (CE)
US$ 0.000001
(-99.00%)
375
RONNRonn Motor Group Inc (PK)
US$ 0.0002
(0.00%)
111.48M
RDARRaadr Inc (PK)
US$ 0.0007
(0.00%)
27.43M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(0.00%)
24.77M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00235
(-2.08%)
24.52M
CBDDCBD of Denver Inc (PK)
US$ 0.0002
(33.33%)
20.91M

Discussion

View Full Feed
santafe2 santafe2 2 minutes ago
It's been a good run over the last 12 years but I've talked with both of my daughters about the business and neither one of them ever want to do this. LOL!

So I've been slowly selling or moving rentals into long term lease-buy contracts. I'm more of a banker than an investor these day
Buyout Bajillions Buyout Bajillions 2 minutes ago
I'm getting closer and closer to my 11 million share goal. Never been a better time to buy this stock. I told everyone that the main markets were more susceptible to a drop than ELTP. ETLP has one of THE best floors in the market AND one of the best ceilings. That's beyond impressive for an OTC comp
ELTP
Ned4Flanders Ned4Flanders 3 minutes ago
Just a teaser. The real Management Presentation wil be something else baby! 😉
LWLG
BottomBounce BottomBounce 3 minutes ago
https://x.com/vegastarr/status/1809172747194376603 $T
T
Hoghead7 Hoghead7 3 minutes ago
Definitely the 1st quarter
FCEL
igotthemojo igotthemojo 3 minutes ago
“Are you paid to bash it?”

Who would pay to bash a stock that is failing so miserably that it has dropped from $29 to 20 cents?…

Few is doing a great job trashing this company all by himself…he doesn’t need any help…
FCEL
Shawonsarker84 Shawonsarker84 3 minutes ago
Amen!
HMBL
getmoreshares getmoreshares 4 minutes ago
time to jump back in-- lets do it again
BHAT
BottomBounce BottomBounce 4 minutes ago
$VZ https://x.com/CryptoStu3/status/1781957656803955172
VZ
Hoghead7 Hoghead7 4 minutes ago
No one posting on these boards is wealthy, but everyone posting has a vested interest. I post to share facts so everyone has an opportunity to make knowledgeable investment decisions. You are absolutely correct. Those bashers, especially if posting nonsense like BK is imminent, are trying to inst
FCEL
I-Glow I-Glow 4 minutes ago
Actually finally a S-1 under the 1940 is much more arduous than filing through the Securities Act of 1933.
Investment Company Act of 1940: S-1 in Context (the 1940 act is for investment companies and and I have never seen one approved for a OTC company pass comments for a S-1 using the 1940 a
FORW SPZI
I-Glow I-Glow 4 minutes ago
Actually finally a S-1 under the 1940 is much more arduous than filing through the Securities Act of 1933.
Investment Company Act of 1940: S-1 in Context (the 1940 act is for investment companies and and I have never seen one approved for a OTC company pass comments for a S-1 using the 1940 a
FORW SPZI
Tamboo Tamboo 5 minutes ago
Gvsi missing financial statements but Comiing soon New pricd $200000000 Ha Ha 
GVSI
al44 al44 5 minutes ago
GM posh-

That's the way of the left

.................al
Duma Duma 5 minutes ago
Not a good look

https://investorshub.advfn.com/uimage/uploads/2025/3/11/sgrnxx.png
3331 3331 5 minutes ago
b]BIEL+25% GOLDEN CROSS BREAKOUT!
Lonewolf1 Lonewolf1 5 minutes ago
It's all just "clowning" as far as I'm concerned. The furthest thing from natural, normal trading.

Awaiting CGAC reporting.

Tick tock.......
CGAC
Buyout Bajillions Buyout Bajillions 5 minutes ago
Don't tell Nasrat what to do. He doesn't work for you. You have no shares. He works for us - the shareholders. Back to your cave, goat.
ELTP
Aquahoya Aquahoya 5 minutes ago
Let's talk as if you are correct. Then, why are you even here? Why did you decide to come to this ticker to present something that you could have provided to the other 1000s of tickers exist? Why are you here at this ticker right as a new owner is about to bring this current? Why not a month or 2 ag
VGTL
Panzer Panzer 5 minutes ago
Make Commander Sternberger Great Again 
SIPC
3331 3331 6 minutes ago
BIEL+25% GOLDEN CROSS BREAKOUT!
go_wamu go_wamu 6 minutes ago
Just leave him alone! He doesn't have much time left anyway!
We'll find out sooner, rather than later!
COOP
Tamboo Tamboo 6 minutes ago
Every day same story GVSI missing financial statements from Three years Here I enjoy posting GVSI coming soon $100000000 even financial misiing HaHa Ha Ha 
GVSI
Panzer Panzer 6 minutes ago
Panzers still frozen in central Russia waiting to be thawed and thrust back into action 
SIPC

Your Recent History

USOTC
CSLLY
Csl (QX)
NEO
EAGB.U
Emerge Ark Genomics & Bi...
TSXV
GLAD
Gladiator Metals
AMEX
SPXS
Direxion Daily S&P 500 B...
AMEX
ZOCT
Innovator Equity Defined...
NYSE
HYLN
Hyliion
USOTC
TONR
Tonner One World (PK)
NYSE
QS
Quantumscape
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads